Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1

Conditions

Multiple Endocrine Neoplasia Type 1 1Depression 1

Interventions

Cyclophosphamide 908Carboplatin 785Paclitaxel 739pembrolizumab 738Cisplatin 707Bevacizumab 705Gemcitabine 619Docetaxel 578Rituximab 548Radiotherapy 539Dexamethasone 510Nivolumab 485Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 357Pemetrexed 334Cytarabine 334Oxaliplatin 333Lenalidomide 327Prednisone 326fludarabine phosphate 315Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Mass Screening × Clear all
NCT01980771 2021-10-27

Barbershop Talk: HIV Prevention for African American Heterosexual Men

State University of New York - Downstate Medical Center

Phase NA Completed
860 enrolled 7 charts
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT02273206 2020-03-12

PCM3

Clinical Directors Network

Phase NA Completed
802 enrolled 28 charts

Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡